Efficacy and Safety of Lenalidomide (Len) Versus Placebo (Pbo) in Rbc-Transfusion Dependent (Td) Patients (Pts) with Ipss Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (Mds) Without Del(5Q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (Esas): Results from a Randomized Phase 3 Study (Cc-5013-Mds-005)

AuthID
 P-00A-8BQ
20
Author(s)
Santini, V
·
Giagounidis, A
·
Vey, N
·
Mufti, GJ
·
Buckstein, R
·
Mittelman, M
·
Platzbecker, U
·
Shpilberg, O
·
Ram, R
·
del Canizo, C
·
Gattermann, N
·
Ozawa, K
·
Zhong, J
·
Seguy, F
·
Hoenekopp, A
·
Beach, CL
·
Fenaux, P
Document Type
Abstract
Year published
2014
Published
in BLOOD, ISSN: 0006-4971
Volume: 124, Issue: 21
Conference
56Th Annual Meeting of the American-Society-Of-Hematology, Date: DEC 06-09, 2014, Location: San Francisco, CA, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000349233804048
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service